To Err is Human, to De-Risk Divine...

We live in an age where we wish to de-risk our investments.  Today in the highly competitive pharmaceutical sector, if you don't spot potential risks before they become a danger to the patient, and a regulator can prove you had the information to mitigate them, you are liable to face one or more of the following: closure of your business unit, a prosecution case that could lead to a jail sentence, and personal responsibility for the serious illness or death of a patient.  So far, so obvious the need to de-risk.

To read the article in full please click on the pdf link below:

How to build risk management into Clinical Trials

For further information please contact Kate Adams at kate.adams@wcigroup.com